Skip to main content
NCBI home page
The British Journal of Ophthalmology logoLink to The British Journal of Ophthalmology
. 1966 Dec;50(12):710–717. doi: 10.1136/bjo.50.12.710

Anti-inflammatory effect of oxyphenbutazone after cataract and squint operations.

V H Smith, P D Fowler
PMCID: PMC506309  PMID: 5957151

Full text

PDF
710

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ALLGOEWER M., BURRI C., von GRAFFENRIED, GRUBER U. F., HEIM U., MENG J., SEGMUELLER G., SIEGRIST J., STUDER E. [Quantitative analysis of the effects of antiphlogistic substances in lower leg fractures]. Schweiz Med Wochenschr. 1963 Apr 13;93:565–567. [PubMed] [Google Scholar]
  2. ASHTON N., COOK C. Effect of cortisone on healing of corneal wounds. Br J Ophthalmol. 1951 Nov;35(11):708–717. doi: 10.1136/bjo.35.11.708. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. BANNERJEE S. K., TAYLOR P. Hydroxyphenylbutazone in the treatment of nodular scleritis. Trans Ophthalmol Soc U K. 1961;81:651–652. [PubMed] [Google Scholar]
  4. BARCELO R., LEBLANC C., RIOPEL P., LEGRESLEY L. P. Effects of oxyphenbutazone (tandearil) on plasma seromucoids. II. In postoperative inflammation. Can Med Assoc J. 1963 Mar 23;88:606–610. [PMC free article] [PubMed] [Google Scholar]
  5. CATALANO G. B., ROSSI M. [The use of oxyphenylbutazone (G-27202) in the prevention of postoperative complications in O.R.L. surgerv]. Clin Otorinolaringoiatr. 1960 Sep-Oct;12:383–390. [PubMed] [Google Scholar]
  6. DUNNINGTON J. H. Ocular wound healing with particular reference to the cataract incision. Trans Opthal Soc U K. 1955;75:137–171. [PubMed] [Google Scholar]
  7. FRASER W. D., BEARDALL P. J., MAUGHAN G. B. A preliminary report of the anti-inflammatory effect of oxyphenbutazone (G27202) in postoperative obstetrical and gynecological practice. Can Med Assoc J. 1961 Aug 5;85:295–298. [PMC free article] [PubMed] [Google Scholar]
  8. GORDON D. M., MCLEAN J. M., KOTEEN H. Present status of corticotropin; ACTH, cortisone, and hydrocortisone in ophthalmology. Br J Ophthalmol. 1953 Feb;37(2):85–98. doi: 10.1136/bjo.37.2.85. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. HOPPING W. [On the effectiveness of Tanderil in inflammatory irritations and swellings of the eye]. Klin Monbl Augenheilkd. 1963 Jul;142:1061–1063. [PubMed] [Google Scholar]
  10. LEOPOLD I. H., PURNELL J. E., CANNON E. J., STEINMETZ C. G., McDONALD P. R. Local and systemic cortisone in ocular disease. Am J Ophthalmol. 1951 Mar;34(3):361–371. doi: 10.1016/0002-9394(51)91481-x. [DOI] [PubMed] [Google Scholar]
  11. NEWELL F. W., DIXON J. M. Effect of subconjunctival cortisone upon the immediate union of experimental corneal grafts. Am J Ophthalmol. 1951 Jul;34(7):977–982. doi: 10.1016/0002-9394(51)91164-6. [DOI] [PubMed] [Google Scholar]
  12. WERNER L. E. Hydroxy-phenylbutazone (Tanderil) in the treatment of ocular disease. A preliminary survey. Br J Ophthalmol. 1960 Dec;44:755–760. doi: 10.1136/bjo.44.12.755. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. WILHELMI G. [Pharmacological properties of the metabolites of 1,2-diphenyl-3,5-dioxo-4-n-butylpyrazolidine]. Arzneimittelforschung. 1960 Feb;10:129–133. [PubMed] [Google Scholar]
  14. WOODS A. C. Uses and limitations of ACTH and cortisone in ophthalmology. Br J Ophthalmol. 1952 Aug;36(8):401–431. doi: 10.1136/bjo.36.8.401. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Publishing Group

RESOURCES